Back
ACVC Premium Access

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Conclusion.

Session: Dual or triple antithrombotic therapy?
Topic: Clinical
Speaker: Professor P. Clemmensen (Hamburg, DE)
Event: Acute Cardiovascular Care 2019

Presentation

0

About the speaker

Professor Peter Michael Clemmensen

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
9 presentations
0 follower

5 more presentations in this session

Positioning of the topic - DAT for all ACS patients with atrial fibrillation receiving coronary stents

Speaker: Professor K. Huber (Vienna, AT)

Access
Slides
0
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - PRO

Speaker: Doctor A. Sambola (Barcelona, ES)

Access
Slides
0
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - CONTRA

Speaker: Doctor A. Rubboli (Ravenna, IT)

Access
Slides
Video
0
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Rebuttal

Speaker: Doctor A. Rubboli (Ravenna, IT) Doctor A. Sambola (Barcelona, ES)

Access
0
Thumbnail

Dual therapy for all ACS patients with atrial fibrillation receiving coronary stents - Moderated discussion.

Speaker: Professor K. Huber (Vienna, AT)

Access
0
Thumbnail

Access the full session

Dual or triple antithrombotic therapy?

Speakers: Professor P. Clemmensen, Professor K. Huber, Doctor A. Sambola, Doctor A. Rubboli, Doctor A. Rubboli...
Access
0
Thumbnail

About the event

Image

Acute Cardiovascular Care 2019

2 March - 4 March 2019

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Hot off the press: latest updates on new therapeutic approaches to HFrEF – discussion.

29 August 2021

ESC Premium Access

HFpEF as a cardiometabolic syndrome.

29 August 2021

Open Access

Panel discussion with audience Q&A.

27 August 2021

This platform is supported by

logo Novo Nordisk